# Postspinal Surgery Hydrocephalus, Intraventricular Hemorrhage, and Multidrug-Resistant Ventriculitis: A Fatal Cascade

**Authors:** Zeinab El Mawla, Abbas Shoeib, Zahraa Shamas, Ahmad Awde, Ali Raad

PMC · DOI: 10.1055/a-2798-9840 · Journal of Neurological Surgery Reports · 2026-02-09

## TL;DR

A rare and deadly combination of brain fluid buildup, bleeding, and drug-resistant infection occurred after spinal surgery, leading to a patient's death despite treatment.

## Contribution

This case highlights the fatal cascade of hydrocephalus, IVH, and multidrug-resistant ventriculitis after spinal surgery.

## Key findings

- Coexisting hydrocephalus, IVH, and CRE ventriculitis significantly worsen prognosis.
- Intrathecal antibiotics achieved microbiological clearance but failed to prevent death.
- Early recognition and aggressive therapy are critical for managing this complication cascade.

## Abstract

Hydrocephalus, intraventricular hemorrhage (IVH), and ventriculitis are rare but devastating complications following spinal surgery. Their coexistence significantly worsens prognosis, especially when multidrug-resistant pathogens are involved.

A 59-year-old man with a C7 fracture and complete paraplegia underwent anterior and posterior cervical spine surgeries complicated by cerebrospinal fluid (CSF) leakage. He later developed hydrocephalus and IVH, requiring external ventricular drainage. Shortly thereafter, fever and altered consciousness occurred, and pus was observed in the drain. CSF analysis confirmed carbapenem-resistant
Enterobacteriaceae
(CRE) ventriculitis, specifically caused by
Escherichia coli
. Treatment with intravenous meropenem, vancomycin, and escalation to intrathecal colistin and tigecycline achieved microbiological clearance. Despite this, neurological recovery was poor, and the patient succumbed 27 days after readmission.

This report emphasizes the interplay of mechanical and infectious complications after spinal surgery, highlighting the need for early recognition, aggressive combined therapy, and preventive strategies to improve outcomes.

## Linked entities

- **Chemicals:** meropenem (PubChem CID 441130), vancomycin (PubChem CID 14969), colistin (PubChem CID 5311054), tigecycline (PubChem CID 54686904)
- **Diseases:** hydrocephalus (MONDO:0001150), paraplegia (MONDO:0003757)

## Full-text entities

- **Diseases:** IVH (MESH:D000074042), C7 fracture (MESH:C566443), Hydrocephalus (MESH:D006849), infectious (MESH:D003141), paraplegia (MESH:D010264), altered consciousness (MESH:D003244), fever (MESH:D005334), Ventriculitis (MESH:D058565)
- **Chemicals:** carbapenem (MESH:D015780), vancomycin (MESH:D014640), tigecycline (MESH:D000078304), meropenem (MESH:D000077731)
- **Species:** Enterobacteriaceae (enterobacteria, family) [taxon 543], Escherichia coli (E. coli, species) [taxon 562], Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12885763/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12885763/full.md

## References

14 references — full list in the complete paper: https://tomesphere.com/paper/PMC12885763/full.md

---
Source: https://tomesphere.com/paper/PMC12885763